Enzomac Tablet is a combination pharmaceutical formulation containing Bromelain (90mg), Trypsin (48mg), and Rutoside (100mg), designed to provide anti-inflammatory, proteolytic, and vasoprotective effects. Bromelain, a proteolytic enzyme derived from pineapple stems, facilitates the breakdown of proteins, thereby reducing inflammation and edema in various acute and chronic inflammatory conditions. Trypsin, another proteolytic enzyme, complements Bromelain by enhancing the degradation of inflammatory mediators and promoting tissue repair. Rutoside, a bioflavonoid, exerts antioxidant and capillary-strengthening properties, improving microcirculation and reducing capillary permeability and fragility. This combination is commonly indicated for the management of inflammatory disorders such as post-traumatic edema, postoperative swelling, and chronic venous insufficiency. Enzomac Tablet aids in accelerating the resolution of inflammation, alleviating pain, and enhancing tissue healing. The synergistic action of these active ingredients makes Enzomac effective in reducing swelling, bruising, and discomfort associated with musculoskeletal injuries and vascular conditions. It is generally well-tolerated; however, patients with hypersensitivity to any component should avoid use. Enzomac should be administered under medical supervision, with dosage tailored to the severity of the condition and patient response.